Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas

A Key Role of Ezrin

Luana Lugini, Francesco Lozupone, Paola Matarrese, Cristina Funaro, Francesca Luciani, Walter Malorni, Licia Rivoltini, Chiara Castelli, Antonella Tinari, Adriano Piris, Giorgio Parmiani, Stefano Fais

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Features of phagocytosis have been observed in human tumors, but the phagocytic apparatus of tumor cells and the mechanism(s) underlying this phenomenon have yet to be defined. To address the phenomenon of phagocytosis, its underlying mechanism(s), and its possible role in tumor biology, we used human melanoma cells as a prototypic model. Our results showed that a process of phagocytosis of apoptotic cells occurs in vivo in human melanoma. This finding was consistent with evidence that human melanoma cells in vitro express all of the known lysosomal and phagocytic markers on their cytoplasmic vesicles and that a process of phagocytosis occurs in these vesicles. However, exclusively human melanoma cells deriving from metastatic lesions possess an efficient phagocytic machinery responsible for a macrophage-like activity against latex beads, yeast, and apoptotic cells of different origins, which was comparable to that of human primary macrophages. Moreover, the actin-binding protein ezrin was expressed on phagocytic vacuoles of melanoma cells and of cells deriving from a human adenocarcinoma; both treatment with cytochalasin B and specific inhibition of ezrin synthesis strongly affected the phagocytic activity of melanoma cells. This suggests that the association with the actin cytoskeleton is a crucial requirement for the development of this phenomenon. Hence our data provide evidence for a potent phagocytic activity exerted by metastatic melanoma cells possibly involved in determining the level of aggressiveness of human melanoma. This suggests that the assessment of phagocytic activity may be exploited as a new tool to evaluate the malignancy of human melanoma. Moreover, our data suggest that gene therapy or drug treatments aimed at inhibiting actin assembly to the phagosomal membranes may be proposed as a new strategy for the control of tumor aggressiveness.

Original languageEnglish
Pages (from-to)1555-1567
Number of pages13
JournalLaboratory Investigation
Volume83
Issue number11
DOIs
Publication statusPublished - Nov 2003

Fingerprint

Melanoma
Phagocytosis
Neoplasms
Macrophages
Cytoplasmic Vesicles
ezrin
Cytophagocytosis
Microfilament Proteins
Cytochalasin B
Vacuoles
Actin Cytoskeleton
Microspheres
Genetic Therapy
Actins
Adenocarcinoma
Yeasts
Membranes
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Lugini, L., Lozupone, F., Matarrese, P., Funaro, C., Luciani, F., Malorni, W., ... Fais, S. (2003). Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas: A Key Role of Ezrin. Laboratory Investigation, 83(11), 1555-1567. https://doi.org/10.1097/01.LAB.0000098425.03006.42

Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas : A Key Role of Ezrin. / Lugini, Luana; Lozupone, Francesco; Matarrese, Paola; Funaro, Cristina; Luciani, Francesca; Malorni, Walter; Rivoltini, Licia; Castelli, Chiara; Tinari, Antonella; Piris, Adriano; Parmiani, Giorgio; Fais, Stefano.

In: Laboratory Investigation, Vol. 83, No. 11, 11.2003, p. 1555-1567.

Research output: Contribution to journalArticle

Lugini, L, Lozupone, F, Matarrese, P, Funaro, C, Luciani, F, Malorni, W, Rivoltini, L, Castelli, C, Tinari, A, Piris, A, Parmiani, G & Fais, S 2003, 'Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas: A Key Role of Ezrin', Laboratory Investigation, vol. 83, no. 11, pp. 1555-1567. https://doi.org/10.1097/01.LAB.0000098425.03006.42
Lugini, Luana ; Lozupone, Francesco ; Matarrese, Paola ; Funaro, Cristina ; Luciani, Francesca ; Malorni, Walter ; Rivoltini, Licia ; Castelli, Chiara ; Tinari, Antonella ; Piris, Adriano ; Parmiani, Giorgio ; Fais, Stefano. / Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas : A Key Role of Ezrin. In: Laboratory Investigation. 2003 ; Vol. 83, No. 11. pp. 1555-1567.
@article{516dae5d78354f50b1fb8f8470548120,
title = "Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas: A Key Role of Ezrin",
abstract = "Features of phagocytosis have been observed in human tumors, but the phagocytic apparatus of tumor cells and the mechanism(s) underlying this phenomenon have yet to be defined. To address the phenomenon of phagocytosis, its underlying mechanism(s), and its possible role in tumor biology, we used human melanoma cells as a prototypic model. Our results showed that a process of phagocytosis of apoptotic cells occurs in vivo in human melanoma. This finding was consistent with evidence that human melanoma cells in vitro express all of the known lysosomal and phagocytic markers on their cytoplasmic vesicles and that a process of phagocytosis occurs in these vesicles. However, exclusively human melanoma cells deriving from metastatic lesions possess an efficient phagocytic machinery responsible for a macrophage-like activity against latex beads, yeast, and apoptotic cells of different origins, which was comparable to that of human primary macrophages. Moreover, the actin-binding protein ezrin was expressed on phagocytic vacuoles of melanoma cells and of cells deriving from a human adenocarcinoma; both treatment with cytochalasin B and specific inhibition of ezrin synthesis strongly affected the phagocytic activity of melanoma cells. This suggests that the association with the actin cytoskeleton is a crucial requirement for the development of this phenomenon. Hence our data provide evidence for a potent phagocytic activity exerted by metastatic melanoma cells possibly involved in determining the level of aggressiveness of human melanoma. This suggests that the assessment of phagocytic activity may be exploited as a new tool to evaluate the malignancy of human melanoma. Moreover, our data suggest that gene therapy or drug treatments aimed at inhibiting actin assembly to the phagosomal membranes may be proposed as a new strategy for the control of tumor aggressiveness.",
author = "Luana Lugini and Francesco Lozupone and Paola Matarrese and Cristina Funaro and Francesca Luciani and Walter Malorni and Licia Rivoltini and Chiara Castelli and Antonella Tinari and Adriano Piris and Giorgio Parmiani and Stefano Fais",
year = "2003",
month = "11",
doi = "10.1097/01.LAB.0000098425.03006.42",
language = "English",
volume = "83",
pages = "1555--1567",
journal = "Laboratory Investigation",
issn = "0023-6837",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Potent Phagocytic Activity Discriminates Metastatic and Primary Human Malignant Melanomas

T2 - A Key Role of Ezrin

AU - Lugini, Luana

AU - Lozupone, Francesco

AU - Matarrese, Paola

AU - Funaro, Cristina

AU - Luciani, Francesca

AU - Malorni, Walter

AU - Rivoltini, Licia

AU - Castelli, Chiara

AU - Tinari, Antonella

AU - Piris, Adriano

AU - Parmiani, Giorgio

AU - Fais, Stefano

PY - 2003/11

Y1 - 2003/11

N2 - Features of phagocytosis have been observed in human tumors, but the phagocytic apparatus of tumor cells and the mechanism(s) underlying this phenomenon have yet to be defined. To address the phenomenon of phagocytosis, its underlying mechanism(s), and its possible role in tumor biology, we used human melanoma cells as a prototypic model. Our results showed that a process of phagocytosis of apoptotic cells occurs in vivo in human melanoma. This finding was consistent with evidence that human melanoma cells in vitro express all of the known lysosomal and phagocytic markers on their cytoplasmic vesicles and that a process of phagocytosis occurs in these vesicles. However, exclusively human melanoma cells deriving from metastatic lesions possess an efficient phagocytic machinery responsible for a macrophage-like activity against latex beads, yeast, and apoptotic cells of different origins, which was comparable to that of human primary macrophages. Moreover, the actin-binding protein ezrin was expressed on phagocytic vacuoles of melanoma cells and of cells deriving from a human adenocarcinoma; both treatment with cytochalasin B and specific inhibition of ezrin synthesis strongly affected the phagocytic activity of melanoma cells. This suggests that the association with the actin cytoskeleton is a crucial requirement for the development of this phenomenon. Hence our data provide evidence for a potent phagocytic activity exerted by metastatic melanoma cells possibly involved in determining the level of aggressiveness of human melanoma. This suggests that the assessment of phagocytic activity may be exploited as a new tool to evaluate the malignancy of human melanoma. Moreover, our data suggest that gene therapy or drug treatments aimed at inhibiting actin assembly to the phagosomal membranes may be proposed as a new strategy for the control of tumor aggressiveness.

AB - Features of phagocytosis have been observed in human tumors, but the phagocytic apparatus of tumor cells and the mechanism(s) underlying this phenomenon have yet to be defined. To address the phenomenon of phagocytosis, its underlying mechanism(s), and its possible role in tumor biology, we used human melanoma cells as a prototypic model. Our results showed that a process of phagocytosis of apoptotic cells occurs in vivo in human melanoma. This finding was consistent with evidence that human melanoma cells in vitro express all of the known lysosomal and phagocytic markers on their cytoplasmic vesicles and that a process of phagocytosis occurs in these vesicles. However, exclusively human melanoma cells deriving from metastatic lesions possess an efficient phagocytic machinery responsible for a macrophage-like activity against latex beads, yeast, and apoptotic cells of different origins, which was comparable to that of human primary macrophages. Moreover, the actin-binding protein ezrin was expressed on phagocytic vacuoles of melanoma cells and of cells deriving from a human adenocarcinoma; both treatment with cytochalasin B and specific inhibition of ezrin synthesis strongly affected the phagocytic activity of melanoma cells. This suggests that the association with the actin cytoskeleton is a crucial requirement for the development of this phenomenon. Hence our data provide evidence for a potent phagocytic activity exerted by metastatic melanoma cells possibly involved in determining the level of aggressiveness of human melanoma. This suggests that the assessment of phagocytic activity may be exploited as a new tool to evaluate the malignancy of human melanoma. Moreover, our data suggest that gene therapy or drug treatments aimed at inhibiting actin assembly to the phagosomal membranes may be proposed as a new strategy for the control of tumor aggressiveness.

UR - http://www.scopus.com/inward/record.url?scp=10744231987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744231987&partnerID=8YFLogxK

U2 - 10.1097/01.LAB.0000098425.03006.42

DO - 10.1097/01.LAB.0000098425.03006.42

M3 - Article

VL - 83

SP - 1555

EP - 1567

JO - Laboratory Investigation

JF - Laboratory Investigation

SN - 0023-6837

IS - 11

ER -